Sat Prabhava’s precision oncology services decode your tumour’s genetic and molecular profile to guide truly personalised care. From targeted drugs to immune strategies, we match the right treatment to your biology.
Personalised Cancer Treatment Informed by Your Genetic Blueprint
At Sat Prabhava, our Onco-Molecular Genetics and Precision Oncology service is the cornerstone of personalised cancer care. Using advanced genomic, transcriptomic, and epigenetic profiling, we uncover the unique molecular blueprint of your cancer to guide targeted, evidence-based treatment decisions.
Our testing includes analysis of oncogenes, tumour suppressor mutations, drug-resistance markers, immune signatures, and metabolic pathway activators. These insights allow us to identify therapies most likely to succeed—whether it’s chemotherapy, targeted inhibitors, immunotherapy, or natural compounds that modulate specific gene expressions.
This data-driven approach is paired with chemosensitivity testing, natural substance sensitivity assays, and immune biomarker profiling, giving us a comprehensive understanding of your tumour’s behaviour and vulnerabilities. Every plan is reviewed by a multidisciplinary panel, ensuring your treatment is not only personalised—but scientifically sound and adaptable as you progress.
“At Sat Prabhava, we don’t just treat the tumour—we decode it. Precision oncology gives us a roadmap, so your care is smarter, safer, and built around your unique biology.”